These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2638582)

  • 21. Lack of withdrawal symptoms after discontinuation of mianserin.
    Otani K; Sasa H; Kaneko S; Fukushima Y
    Lancet; 1991 Mar; 337(8742):673-4. PubMed ID: 1672010
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
    Oertel W; Trenkwalder C; Beneš H; Ferini-Strambi L; Högl B; Poewe W; Stiasny-Kolster K; Fichtner A; Schollmayer E; Kohnen R; García-Borreguero D;
    Lancet Neurol; 2011 Aug; 10(8):710-20. PubMed ID: 21705273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involuntary movements associated with mianserin treatment. A case report.
    Otani K; Kaneko S; Fukushima Y; Kubota S
    Br J Psychiatry; 1989 Jan; 154():113-4. PubMed ID: 2775939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mianserin withdrawal and the pupil response of depressed and recovered patients: a preliminary report.
    Muijen M; Jones DP; Roy D; Silverstone T; Mehmet A
    Biol Psychiatry; 1989 Mar; 25(6):810-4. PubMed ID: 2923942
    [No Abstract]   [Full Text] [Related]  

  • 25. [Alimemazine-induced restless legs syndrome: About two cases].
    Gonzalez C; Gras-Champel V; Masmoudi K
    Therapie; 2017 Dec; 72(6):709-710. PubMed ID: 28647108
    [No Abstract]   [Full Text] [Related]  

  • 26. Olanzapine-induced restless legs syndrome.
    Zhao M; Geng T; Qiao L; Zhang M; Shi J; Huang F; Lin X; Wang J; Zuo H
    J Clin Neurosci; 2014 Sep; 21(9):1622-5. PubMed ID: 24874697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seizures following the withdrawal of long-term treatment with mianserin.
    De Leo D; Dalla Barba G; Zanchin G
    Ital J Neurol Sci; 1988 Apr; 9(2):167-9. PubMed ID: 3397273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
    Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
    J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
    [No Abstract]   [Full Text] [Related]  

  • 29. Topiramate-induced restless legs syndrome: a report of two cases.
    Romigi A; Izzi F; Placidi F; Sperli F; Cervellino A; Marciani MG
    J Neurol; 2007 Aug; 254(8):1120-1. PubMed ID: 17473947
    [No Abstract]   [Full Text] [Related]  

  • 30. Restless legs, anxiety and caffeinism.
    Lutz EG
    J Clin Psychiatry; 1978 Sep; 39(9):693-8. PubMed ID: 690085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia.
    Brown LK; Dedrick DL; Doggett JW; Guido PS
    Sleep Med; 2005 Sep; 6(5):443-50. PubMed ID: 16084763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database.
    Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ;
    J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium-aggravated nocturnal myoclonus and restless legs syndrome.
    Heiman EM; Christie M
    Am J Psychiatry; 1986 Sep; 143(9):1191-2. PubMed ID: 3752305
    [No Abstract]   [Full Text] [Related]  

  • 34. Placebo-controlled study of mianserin in depressed outpatients.
    McGrath PJ; Rabkin JG; Stewart JW; Harrison W; Quitkin FM; Markowitz J
    Neuropsychobiology; 1985; 14(3):128-32. PubMed ID: 3913875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mianserin agranulocytosis followed by oxitriptan eosinophilia].
    García C
    Nervenarzt; 1992 May; 63(5):303-7. PubMed ID: 1603192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment.
    Koponen H; Honkonen S; Partanen J; Riekkinen PJ
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):379. PubMed ID: 2056337
    [No Abstract]   [Full Text] [Related]  

  • 37. Delirium associated with mianserin.
    Bonne O; Shalev AY; Bloch M
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):147-9. PubMed ID: 7549457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Akathisia associated with mianserin.
    Aggarwal A; Khandelwal A; Garg A; Jiloha RC
    J Clin Psychopharmacol; 2010 Jun; 30(3):338-9. PubMed ID: 20473077
    [No Abstract]   [Full Text] [Related]  

  • 39. Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature.
    Rittmannsberger H; Werl R
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1427-31. PubMed ID: 23331473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia.
    Kang SG; Lee HJ; Park YM; Yang HJ; Song HM; Lee YJ; Cho SJ; Cho SN; Kim L
    Hum Psychopharmacol; 2013 Mar; 28(2):117-23. PubMed ID: 23361623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.